Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

516 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nongenetic method for purifying stem cell-derived cardiomyocytes.
Hattori F, Chen H, Yamashita H, Tohyama S, Satoh YS, Yuasa S, Li W, Yamakawa H, Tanaka T, Onitsuka T, Shimoji K, Ohno Y, Egashira T, Kaneda R, Murata M, Hidaka K, Morisaki T, Sasaki E, Suzuki T, Sano M, Makino S, Oikawa S, Fukuda K. Hattori F, et al. Among authors: yamakawa h. Nat Methods. 2010 Jan;7(1):61-6. doi: 10.1038/nmeth.1403. Epub 2009 Nov 29. Nat Methods. 2010. PMID: 19946277
Disease characterization using LQTS-specific induced pluripotent stem cells.
Egashira T, Yuasa S, Suzuki T, Aizawa Y, Yamakawa H, Matsuhashi T, Ohno Y, Tohyama S, Okata S, Seki T, Kuroda Y, Yae K, Hashimoto H, Tanaka T, Hattori F, Sato T, Miyoshi S, Takatsuki S, Murata M, Kurokawa J, Furukawa T, Makita N, Aiba T, Shimizu W, Horie M, Kamiya K, Kodama I, Ogawa S, Fukuda K. Egashira T, et al. Among authors: yamakawa h. Cardiovasc Res. 2012 Sep 1;95(4):419-29. doi: 10.1093/cvr/cvs206. Epub 2012 Jun 27. Cardiovasc Res. 2012. PMID: 22739119
Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes.
Tohyama S, Hattori F, Sano M, Hishiki T, Nagahata Y, Matsuura T, Hashimoto H, Suzuki T, Yamashita H, Satoh Y, Egashira T, Seki T, Muraoka N, Yamakawa H, Ohgino Y, Tanaka T, Yoichi M, Yuasa S, Murata M, Suematsu M, Fukuda K. Tohyama S, et al. Among authors: yamakawa h. Cell Stem Cell. 2013 Jan 3;12(1):127-37. doi: 10.1016/j.stem.2012.09.013. Epub 2012 Nov 15. Cell Stem Cell. 2013. PMID: 23168164 Free article.
Induction of human cardiomyocyte-like cells from fibroblasts by defined factors.
Wada R, Muraoka N, Inagawa K, Yamakawa H, Miyamoto K, Sadahiro T, Umei T, Kaneda R, Suzuki T, Kamiya K, Tohyama S, Yuasa S, Kokaji K, Aeba R, Yozu R, Yamagishi H, Kitamura T, Fukuda K, Ieda M. Wada R, et al. Among authors: yamakawa h. Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12667-72. doi: 10.1073/pnas.1304053110. Epub 2013 Jul 16. Proc Natl Acad Sci U S A. 2013. PMID: 23861494 Free PMC article. Clinical Trial.
Efficacy and safety of bepridil for prevention of ICD shocks in patients with Brugada syndrome and idiopathic ventricular fibrillation.
Aizawa Y, Yamakawa H, Takatsuki S, Katsumata Y, Nishiyama T, Kimura T, Nishiyama N, Fukumoto K, Tanimoto Y, Tanimoto K, Mitamura H, Ogawa S, Fukuda K. Aizawa Y, et al. Among authors: yamakawa h. Int J Cardiol. 2013 Oct 12;168(5):5083-5. doi: 10.1016/j.ijcard.2013.07.187. Epub 2013 Jul 30. Int J Cardiol. 2013. PMID: 23954005 No abstract available.
MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures.
Muraoka N, Yamakawa H, Miyamoto K, Sadahiro T, Umei T, Isomi M, Nakashima H, Akiyama M, Wada R, Inagawa K, Nishiyama T, Kaneda R, Fukuda T, Takeda S, Tohyama S, Hashimoto H, Kawamura Y, Goshima N, Aeba R, Yamagishi H, Fukuda K, Ieda M. Muraoka N, et al. Among authors: yamakawa h. EMBO J. 2014 Jul 17;33(14):1565-81. doi: 10.15252/embj.201387605. Epub 2014 Jun 11. EMBO J. 2014. PMID: 24920580 Free PMC article.
516 results